SJOGREN'S SYNDROME (SS)
Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME (SS) trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA therapy tested for lupus and other autoimmune conditions
Disease control Recruiting nowThis early-stage trial tests a new mRNA drug called MTS109 in 15 people with moderate to severe autoimmune diseases like lupus, scleroderma, and Sjogren's syndrome. The main goal is to see if the treatment is safe and tolerable. Researchers will also check if it helps control the…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new treatment called YTS109 for people with severe autoimmune diseases like lupus and Sjogren's syndrome that have not responded to standard therapies. About 18 adults will receive a single infusion of these specially designed immune cells. The main…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
Revolutionary In-Body CAR-T therapy targets autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment called TI-0032-III for people with severe autoimmune diseases like lupus and Sjögren's syndrome that haven't improved with standard care. The treatment uses a special injection to create CAR-T cells inside the body, which then target a…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated May 11, 2026 20:49 UTC